![Alexia Pearsall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexia Pearsall
Director of Finance/CFO at Omega Fund Management LLC
Network origin in Alexia Pearsall first degree
Entity | Entity type | Industry | |
---|---|---|---|
Oxford Bioscience Partners
![]() Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.
24
| Private Company | Investment Managers | 24 |
Omega Fund Management LLC
![]() Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US.
22
| Private Company | Investment Managers | 22 |
Guidepost Growth Management Co. LLC
![]() Guidepost Growth Management Co. LLC Investment ManagersFinance Guidepost Growth Management Co. LLC (Guidepost Growth Mgmt) is a private equity subsidiary of North Bridge Venture Partners founded in 2007 by Doug A. Kingsley and Jim M. Moran. The firm is headquartered in Boston, Massachusetts.
20
| Subsidiary | Investment Managers | 20 |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.
6
| Private Company | Investment Managers | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alexia Pearsall via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Nuvation Bio Operating Co., Inc.
![]() Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Aerium Therapeutics, Inc.
![]() Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Chairman | |
OMEGA ALPHA SPAC | Financial Conglomerates | Founder Chief Executive Officer Founder Founder | |
Duke University
![]() Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Mitralign, Inc.
![]() Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Spectrum Equity Management LP
![]() Spectrum Equity Management LP Investment ManagersFinance Spectrum Equity Management LP (Spectrum Equity) is an independent Private Equity firm founded in 1993 by Bill Peter Collatos and Brion Blackwell Applegate. The firm is headquartered in Boston, Massachusetts with an additional office in California. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
OPKO Diagnostics LLC
![]() OPKO Diagnostics LLC Medical/Nursing ServicesHealth Services OPKO Diagnostics LLC engages in the provision of health services. It develops blood testing devices for use in homes and doctors offices. The company was founded by Vincent Linder, George M. Whitesides, David Steinmiller, and Samuel K. Sia in 2004 and is headquartered in Woburn, MA. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Director of Finance/CFO Private Equity Investor | |
NeoMed S.à.r.l. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
OSS Healthcare, Inc. | Director/Board Member Director/Board Member | ||
Outcome Capital LLC
![]() Outcome Capital LLC Investment Banks/BrokersFinance Outcome Capital LLC is a life sciences and healthcare advisory and investment banking firm that specializes in providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering, and corporate finance. The firm was founded by Jonathan R. Wallace and is based in Boston, MA, with subsidiaries in the United States. The firm's multi-disciplinary team of industry experts draws from their broad relationships and a wide range of scientific, operational, strategic, and transactional expertise across the value chain to assist management teams and their boards in navigating both financial and corporate markets and implementing the best path for success. | Investment Banks/Brokers | Corporate Officer/Principal Founder | |
KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Clinical Ink, Inc.
![]() Clinical Ink, Inc. Internet Software/ServicesTechnology Services Clinical Ink, Inc. provides electronic source solutions for clinical research sites. Its solutions include data management, monitoring, clinical sites and patient centric. The company was founded by Douglas E. Pierce Jr. and Tommy Littlejohn on July 19, 2006 and is headquartered in Winston-Salem, NC. | Internet Software/Services | Director/Board Member Director/Board Member | |
University of Pavia | College/University | Graduate Degree Doctorate Degree | |
ViaCell, Inc.
![]() ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
CHIASMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
General Catalyst LLC
![]() General Catalyst LLC Investment ManagersFinance General Catalyst LLC (General Catalyst) is a venture capital firm founded in 2000 by Joel Cutler, David Fialkow, Bill Fitzgerald, David Orfao and John Simon. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of California, Berkeley | College/University | Corporate Officer/Principal Doctorate Degree | |
Bain Capital Ventures LP
![]() Bain Capital Ventures LP Investment ManagersFinance Bain Capital Ventures LP (Bain Capital Ventures) is a venture capital firm founded in 2001. The firm is headquartered in Boston, Massachusetts with additional offices in New York and California. The firm is wholly owned by Bain Capital LP. | Investment Managers | Private Equity Analyst Public Communications Contact | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
Danish BioVenture General Partner ApS
![]() Danish BioVenture General Partner ApS Financial ConglomeratesFinance Danish BioVenture General Partner ApS operates as a general partner and renders investment advice to K/S Danish BioVenture. It manages the administration and acts as a representative of Danish BioVenture in external commercial relations. The company was founded on June 26, 2009 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
The Lek/Alcar Consulting Group, Inc.
![]() The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Cure Ventures Management LP
![]() Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
Coherex Medical, Inc.
![]() Coherex Medical, Inc. Medical SpecialtiesHealth Technology Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT. | Medical Specialties | Director/Board Member Director/Board Member | |
NRG Therapeutics Ltd.
![]() NRG Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services NRG Therapeutics Ltd. is a British neuroscience drug discovery company that focuses on building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and ALS. The company is based in Stevenage, UK, and was founded in 2018 by Neil Miller and Richard Rutter. The company's pre-clinical pipeline of small molecule assets is based on inhibiting the mitochondrial permeability transition pore (mptp) through a novel mechanism of action. Inhibition of the mptp has been shown to protect neurons, reduce neuroinflammation, and extend survival in pre-clinical disease models. Neil Miller has been the CEO since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Chord Therapeutics SA
![]() Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Biotechnology | Chairman Director/Board Member | |
University of Kansas | College/University | Undergraduate Degree Corporate Officer/Principal | |
The General Hospital Corp.
![]() The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
X-Cell Medical, Inc.
![]() X-Cell Medical, Inc. Medical SpecialtiesHealth Technology X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ. | Medical Specialties | Director/Board Member Chairman |
Statistics
International
United States | 43 |
Switzerland | 4 |
United Kingdom | 3 |
Cayman Islands | 2 |
Italy | 2 |
Sectoral
Health Technology | 23 |
Finance | 12 |
Consumer Services | 11 |
Commercial Services | 4 |
Health Services | 3 |
Operational
Director/Board Member | 413 |
Corporate Officer/Principal | 126 |
Private Equity Investor | 87 |
Independent Dir/Board Member | 70 |
Undergraduate Degree | 61 |
Most connected contacts
Insiders | |
---|---|
Ansbert Gadicke | 56 |
Michael Powell | 48 |
Luke Evnin | 42 |
John Maraganore | 38 |
Todd Foley | 38 |
Otello Stampacchia | 37 |
Paul Brooke | 32 |
Dan Cole | 30 |
Claudio Nessi | 25 |
Michael Lytton | 24 |
Omar Amirana | 23 |
Mark P. Carthy | 23 |
Dina Chaya | 23 |
Vincent Ossipow | 22 |
Bernard Davitian | 19 |
- Stock Market
- Insiders
- Alexia Pearsall
- Company connections